Browse
Publications
Preprints
About
About UCL Open: Env.
Aims and Scope
Editorial Board
Indexing
APCs
How to cite
Publishing policies
Editorial policy
Peer review policy
Equality, Diversity & Inclusion
About UCL Press
Contact us
For authors
Information for authors
How it works
Benefits of publishing with us
Submit
How to submit
Preparing your manuscript
Article types
Open Data
ORCID
APCs
Contributor agreement
For reviewers
Information for reviewers
Review process
How to peer review
Peer review policy
My ScienceOpen
Sign in
Register
Dashboard
Search
Browse
Publications
Preprints
About
About UCL Open: Env.
Aims and Scope
Editorial Board
Indexing
APCs
How to cite
Publishing policies
Editorial policy
Peer review policy
Equality, Diversity & Inclusion
About UCL Press
Contact us
For authors
Information for authors
How it works
Benefits of publishing with us
Submit
How to submit
Preparing your manuscript
Article types
Open Data
ORCID
APCs
Contributor agreement
For reviewers
Information for reviewers
Review process
How to peer review
Peer review policy
My ScienceOpen
Sign in
Register
Dashboard
Search
973
publications
Top publications
1525
views
Most viewed
0
reviews
Latest reviews
0
follows
Top followed users
0
followers
Follow
0
edited collections
All edited
0
followed collections
All followed
Publications
973
Genomic amplification of the caprine EDNRA locus might lead to a dose dependent loss of pigmentation
Authors:
F. Menzi
,
I. KELLER
,
I Reber
…
J. Am. Chem. Soc.
Authors:
J Beck
,
J. Vartuli
,
W. Roth
…
Preliminary results of a phase II study of alrizomadlin (APG-115), a novel, small-molecule MDM2 inhibitor, in combination with pembrolizumab in patients (pts) with unresectable or metastatic melanoma or advanced solid tumors that have failed immuno-oncologic (I-O) drugs.
Authors:
Anthony W. Tolcher
,
James A. Reeves
,
Meredith Ann McKean
…
All publications
Record
: found
Orcid
: not found
Profile
: not found
J Beck
Actions
Follow
New message
Share
Twitter
Sina Weibo
Facebook
Email
Statistics